The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera

Current guidelines recommend therapeutic phlebotomy for all polycythemia vera (PV) patients and additional cytoreductive therapy (eg, hydroxyurea [HU]) for high-risk PV patients. Little is known about the impact of these therapies in the real-world setting. We conducted a retrospective cohort study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Podoltsev, Nikolai A., Zhu, Mengxin, Zeidan, Amer M., Wang, Rong, Wang, Xiaoyi, Davidoff, Amy J., Huntington, Scott F., Giri, Smith, Gore, Steven D., Ma, Xiaomei
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Myeloid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199652/
https://ncbi.nlm.nih.gov/pubmed/30333100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018021436
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars